NBP257288PE

Novus Biologicals™ alpha-1B Adrenergic R/ADRA1B Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP257288PE-Each-of-1 In Stock ₹ 31,372.50

NBP257288PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

147

Common Name

alpha-1B Adrenergic R/ADRA1B Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

ADRA1, adrenergic, alpha-1B-, receptor, alpha-1B adrenergic receptor, Alpha-1B adrenoceptor, Alpha-1B adrenoreceptor, alpha-1B-adrenergic receptor, ALPHA1BAR

Label Type

Unlabeled

Quantity

100μL

Source

E.coli

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20°C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

ADRA1B

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-53485. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Related Products

Img

Novus Biologicals™

NBP256802PE

--

Img

Novus Biologicals™

NBP257224PE

--

Img

Novus Biologicals™

NBP257941PE

--

Img

Novus Biologicals™

NBP258092PE

--

Img

Novus Biologicals™

NBP257620PE

--

Img

Novus Biologicals™

NBP258034PE

--

Img

Novus Biologicals™

NBP257722PE

--

Img

Novus Biologicals™

NBP258072PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human alpha-1B Adrenergic R/ADRA1B
  • Source: E.coli Amino Acid Sequence: MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVG The alpha-1B Adrenergic R/ADRA1B Recombinant Protein Antigen is derived from E
  • coli
  • The alpha-1B Adrenergic R/ADRA1B Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.